S&P 500
5,888.55
-0.6%
-$32.99
DJI
42,098.70
-0.6%
-$244.95
NASDAQ
19,100.94
-0.5%
-$98.23
Bitcoin
107,796.00
-1.0%
-1,121.61
AAPL
$200.40
+0.1%
+$0.19
AMZN
$204.64
-0.7%
-$1.38
GOOG
$173.28
-0.4%
-$0.70
META
$643.48
+0.2%
+$1.16
MSFT
$457.40
-0.7%
-$3.28
NVDA
$135.14
-0.3%
-$0.36
TSLA
$356.97
-1.6%
-$5.92
Diagnos (OTC: DGNOF)
$0.16
(-4.9%)
-$0.01
Price as of May 28, 2025, 3:20 p.m. ET
Diagnos Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Diagnos Company Info
Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company offers algorithm development, data analysis, and image processing services. It focuses on the development of its AI tool, Computer Assisted Retina Analysis, which is a tele-ophthalmology platform that integrates with existing equipment and processes at the point of care. The company was founded by Djamel Abdelkader Zighed in 1998 and is headquartered in Brossard, Canada.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.